BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12479269)

  • 1. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.
    Wetherill YB; Petre CE; Monk KR; Puga A; Knudsen KE
    Mol Cancer Ther; 2002 May; 1(7):515-24. PubMed ID: 12479269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
    Wetherill YB; Fisher NL; Staubach A; Danielsen M; de Vere White RW; Knudsen KE
    Cancer Res; 2005 Jan; 65(1):54-65. PubMed ID: 15665279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.
    Hess-Wilson JK; Webb SL; Daly HK; Leung YK; Boldison J; Comstock CE; Sartor MA; Ho SM; Knudsen KE
    Environ Health Perspect; 2007 Nov; 115(11):1646-53. PubMed ID: 18007998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer.
    Wetherill YB; Hess-Wilson JK; Comstock CE; Shah SA; Buncher CR; Sallans L; Limbach PA; Schwemberger S; Babcock GF; Knudsen KE
    Mol Cancer Ther; 2006 Dec; 5(12):3181-90. PubMed ID: 17172422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathways.
    Shah S; Hess-Wilson JK; Webb S; Daly H; Godoy-Tundidor S; Kim J; Boldison J; Daaka Y; Knudsen KE
    Mol Cancer Res; 2008 Sep; 6(9):1507-20. PubMed ID: 18819937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphenol A affects androgen receptor function via multiple mechanisms.
    Teng C; Goodwin B; Shockley K; Xia M; Huang R; Norris J; Merrick BA; Jetten AM; Austin CP; Tice RR
    Chem Biol Interact; 2013 May; 203(3):556-64. PubMed ID: 23562765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
    Lin DL; Whitney MC; Yao Z; Keller ET
    Clin Cancer Res; 2001 Jun; 7(6):1773-81. PubMed ID: 11410519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of Bisphenol A on androgen receptor antagonism.
    Huang X; Cang X; Liu J
    Toxicol In Vitro; 2019 Dec; 61():104621. PubMed ID: 31415812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term oral exposure to safe dose of bisphenol A in association with high-fat diet stimulate the prostatic lesions in a rodent model for prostate cancer.
    Facina CH; Campos SGP; Gonçalves BF; Góes RM; Vilamaior PSL; Taboga SR
    Prostate; 2018 Feb; 78(2):152-163. PubMed ID: 29148069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The xenoestrogen bisphenol A in the Hershberger assay: androgen receptor regulation and morphometrical reactions indicate no major effects.
    Nishino T; Wedel T; Schmitt O; Schönfelder M; Hirtreiter C; Schulz T; Kühnel W; Michna H
    J Steroid Biochem Mol Biol; 2006 Feb; 98(2-3):155-63. PubMed ID: 16406770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro.
    Xu LC; Sun H; Chen JF; Bian Q; Qian J; Song L; Wang XR
    Toxicology; 2005 Dec; 216(2-3):197-203. PubMed ID: 16169144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms.
    Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER
    Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
    Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
    Krishnan AV; Zhao XY; Swami S; Brive L; Peehl DM; Ely KR; Feldman D
    Endocrinology; 2002 May; 143(5):1889-900. PubMed ID: 11956172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
    Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.